While our review is limited by its PubMed-only, English-language scope and the absence of formal risk-of-bias grading, it nonetheless provides the most comprehensive synthesis to date for clinicians considering how to interpret IgM positivity in APS. This evidence concerns the gene CD40LG and autoimmune polyendocrinopathy.